Skip to content
10-Q

Quarterly Report

EXOZYMES INC. EXOZ

0001641172-25-009636

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 12, 2025 8.37M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $8.51M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $9.72M
Current Liabilities Q1 2025 · Mar 31, 2025 $1.44M
Current Liabilities Q1 2025 · Dec 31, 2024 $1.33M
Total Liabilities Q1 2025 · Mar 31, 2025 $2.64M
Total Liabilities Q1 2025 · Dec 31, 2024 $2.61M
Current Assets Q1 2025 · Mar 31, 2025 $9.42M
Current Assets Q1 2025 · Dec 31, 2024 $10.82M
Total Assets Q1 2025 · Mar 31, 2025 $11.53M
Total Assets Q1 2025 · Dec 31, 2024 $13.03M
Shares Diluted Q1 2025 · Mar 31, 2024 6.25M sh
Capex Q1 2025 · Mar 31, 2024 $148.81K
Operating Cash Flow Q1 2025 · Mar 31, 2024 $281.2K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$1.25M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$384.32K
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.16
Eps Basic Q1 2025 · Mar 31, 2024 −$0.16
Sga Expense Q1 2025 · Mar 31, 2024 $730.88K
Rd Expense Q1 2025 · Mar 31, 2024 $277.58K
Net Income Q1 2025 · Mar 31, 2024 −$1.01M
Operating Income Q1 2025 · Mar 31, 2024 −$1.01M